• Kawa F. Dizaye College of Medicine, Hawler Medical University, Erbil, Kurdistan Region, Iraq.
  • Hani H. Mohammed Department of Pharmacology, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.




Hyperlipidemia, Ginger, Rosuvastatin, Fenofibrate, Ezetimibe



Zingiber officinale (Ginger) is the most common used herb worldwide due to its great medicinal and culinary properties. The medicinal properties come from its antihyperlipidemic, anti-inflammatory, antiemetic, antimicrobial, anticancer and carminative actions. 


The present study was designed to evaluate and compare the effectiveness of different doses of Ginger decoction with, rosuvastatin, fenofibrate and ezetimibe on lipid profile, liver function test and MDA level in hyperlipidemic rats.


Fifty-four rats were divided into two groups. The first group included 18 rats and have subdivided into three subgroups each having 6 rats. The first subgroup served as a control. The second and the third subgroup received (2 ml and 4 ml) of ginger extract (10% W/V) daily respectively. The second group included 30 hyperlipidemic rats and they were subsequently subdivided into six subgroups each of 6 rats. The first subgroup served as positive control. The second subgroups received single doses of ginger (10% W/V). The third, fourth and sixth subgroups received Rosuvastatin (15 mg /kg), Fenofibrate (30mg/kg) and Ezetimibe (1mg/kg) respectively. At the end of treatment period (six weeks), all of these groups were subjected to various biochemical analysis of blood


After six weeks of therapy, ginger extract significantly reduced serum total cholesterol, TG and LDL-C of hyperlipidemic rats, while it significantly increased serum HDL in both normal and hyperlipidemic rats. Daily administration of fenofibrate for six weeks caused significant reduction in serum TG and LDL-C and significantly increased serum HDL of hyperlipidemic rats. Whereas using of rosuvastatin (15mg/kg) and ezetimibe (1mg/kg) for six weeks lead to significant reduction in serum total cholesterol, TG, LDL-C and significantly increase in serum HDL in hyperlipidemic rats. Dose of 2 ml ginger 10% (W/V) decoction significantly reduced MDA level in normal rats, Furthermore Ginger extract and the other antihyperlipidemic drugs significantly decreased serum MDA level of hyperlipidemic rats. After 6 weeks of daily ingestion of different doses ginger decoction, serum ALP was significantly increased in normal rats. However, liver function test of hyperlipidemic rats was not significantly affected by ginger decoction. In another hand, rosuvastatin caused a significant elevation in serum ALP, while ezetimibe significantly reduced AST of hyperlipidemic rats.


Zingiber officinale decoction was effective as the other antihyperlipidemic agents in improving lipid profile. Although ginger has an antioxidant effect, but prolonged administration may have a hazardous hepatic side effect.


Walker R. Clinical Pharmacy and Therapeutics E-Book. Elsevier Health Sciences; 2012. 389-411 p.

Katzung BG, Masters SB, Trevor AJ. Basic & clinical pharmacology. A Lange medical book. 2012. xiii, 1229 .

Harvey R. Lippincott’s Illustrated Reviews: Pharmacology, 5th Edition. Medicine & Science in Sports & Exercise. 2012. p. 265–6.

-Dizaye K, Jarjees H. Effects of Omega-3 on lipid profile and haematological parameters in hyperlipidemic rats. Middle East Journal of Internal Medicine. 2014 Sep 1;7(3). DOI: https://doi.org/10.5742/MEIM.2014.92553

Giacosa A, Morazzoni P, Bombardelli E, Riva A, Porro GB, Rondanelli M. Can nausea and vomiting be treated with Ginger extract? Eur Rev Med Pharmacol Sci. 2015;19(7):1291–6. DOI: https://doi.org/10.1155/2015/915087

Dizaye KF, Chalaby LA. Hypolipidemic efficacy of Trigonella Foenum seeds in comparison with Rosuvastatin and Fenofibrate in hyperlipidemic rats. Middle East Journal of Family Medicine. 2015 Sep 1;13(6). DOI: https://doi.org/10.5742/MEWFM.2015.92703

Habib SHM, Makpol S, Hamid NAA, Das S, Ngah WZW, Yusof YAM. Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics. 2008;63(6):807–13. DOI: https://doi.org/10.1590/S1807-59322008000600017

Lete I, Allué J. The Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy. 2016;11–7. DOI: https://doi.org/10.4137/IMI.S36273

Baliga MS, Haniadka R, Pereira MM, D’Souza JJ, Pallaty PL, Bhat HP, Popuri S. Update on thechemopreventive effects of ginger and its phytochemicals. Critical reviews in food science and nutrition. 2011 Jul 1;51(6):499-523. DOI: https://doi.org/10.1080/10408391003698669

Mani DN, Bawankule D, Saroj BK. Hyperlipidemic model: Studying lipid profile in small experimental animal. Int. J. Pharm. Pharm. Sci. 2012;4:337-40.

Munshi RP, Joshi SG, Rane BN. Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance and markers for coronary heart disease. Indian J Pharmacol. 2014;46(3):270–6. DOI: https://doi.org/10.4103/0253-7613.132156

Dhande SR, Gursahani MS, Kadam VJ. Standardization of cholesterol suspension induced hyperlipidemia in rats. 2014;3(12):1107–23.

Prasad S., Kumar S, Vajpeyee S., Bhavsar V. To establish the effect of ginger-juice zingiber officinale (zingiberaceae) important parameters of lipid. Int J Pharma Sci Res. 2012;3(4):352–6.

Berroukche A, Attaoui A, Loth M. Comparative study between effects of ethanol extract of Zingiber officinale and Atorvastatine on lipid profile in rats. J Pharmacogn Phyther. 2016;8(8):155–62. DOI: https://doi.org/10.5897/JPP2015.0369

Tabibi, H., Imani, H., Atabak, S., Najafi, I., Hedayati, M. and Rahmani, L., 2016. Effects of ginger on serum lipids and lipoproteins in peritoneal dialysis patients: a randomized controlled trial. Peritoneal Dialysis International, 36(2), pp.140-145. DOI: https://doi.org/10.3747/pdi.2015.00006

ElRokh ES, Yassin NA, El-Shenawy SM, Ibrahim BM. Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology. 2010 Dec 1;18(6):309-15. DOI: https://doi.org/10.1007/s10787-010-0053-5

Al-Noory AS, Amreen A-N, Hymoor S. Antihyperlipidemic effects of ginger extracts in alloxan-induced diabetes and propylthiouracil-induced hypothyroidism in (rats). Pharmacognosy Res. 2013 Jul;5(3):157–61. DOI: https://doi.org/10.4103/0974-8490.112419

Sun B, Xie Y, Jiang J, Wang Y, Xu X. Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia. Lipids Health Dis. 2015;1–6. DOI: https://doi.org/10.1186/s12944-015-0032-3

Li W, Wang D, Song G, Zuo C, Qiao X, Qin S. The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in rats. Lipids Health Dis. BioMed Central Ltd; 2010;9(1):131. DOI: https://doi.org/10.1186/1476-511X-9-131

Oikawa S, Yamashita S, Nakaya N, Sasaki J, Kono S. Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study. 2017;24:77–94. DOI: https://doi.org/10.5551/jat.35626

Ansari JA, Bhandari U, Pillai KK, Haque SE. Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats — A preliminary study. Indian J Exp Biol. 2012;50(March):216–22.

Rosenson RS, Otvos JD, Hsia J. Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study. Diabetes care. 2009 Jun 1;32(6):1087-91. DOI: https://doi.org/10.2337/dc08-1681

Ruggenenti P, Cattaneo D, ROTA S, ILIEV I, Diadel O, Paranova A, et al. Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes. A prospective randomized double-blind clinical trial. Diabetes Care. 2010;33(9):1954–6. DOI: https://doi.org/10.2337/dc10-0320

Kumagai N, Miura S, Zhang B, Noda K, Saku K. Effects of ezetimibe on hypercholesterolemia in the lipid profile in patients with metabolic syndrome: Zenith Trial. IJCME. Elsevier Ireland Ltd; 2013;1:7–12. DOI: https://doi.org/10.1016/j.ijcme.2013.10.001

Phan BAP, Dayspring TD, Toth PP. Ezetimibe therapy : mechanism of action and clinical update. Vasc Health Risk Manag. 2012;415–27. DOI: https://doi.org/10.2147/VHRM.S33664

Aznar J, Santos M teresa, Valles J, Sala J. Serum malondialdehyde-like material ( MDA-LM ) in acute myocardial infarction. J Clin Pathol. 1983;36:712–5. DOI: https://doi.org/10.1136/jcp.36.6.712

Singh Z, Karthigesu IP, Singh P, Kaur R. Use of malondialdehyde as a biomarker for assessing oxidative stress in different disease pathologies: A review. Iran J Public Health. 2014;43(3):7–16.

Ahmad N, Sulaiman S, Mukti NA, Murad NA, abd hamid noor aini. Effects of Ginger Extract (Zingiber officinale Roscoe) on Antioxidant Status of Hepatocarcinoma Induced Rats. Malaysian J Biochem Mol Biol. 2006;14:7–12.

Abd-allah OM, SHARAF EL-DIN abeer A. The Possible Protective Effect of Ginger Against Intestinal Damage Induced by Methotrexate in Rats. Med J Cairo Univ. 2013;81(1):1073–84.

Yang R, Shi Y, Hao G, Li W, Le G. Increasing Oxidative Stress with Progressive Hyperlipidemia in Human : Relation between Malondialdehyde and Atherogenic Index. J Clin Biochem Nutr. 2008;43(3):154–8. DOI: https://doi.org/10.3164/jcbn.2008044

Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2011;49(4):893–7. DOI: https://doi.org/10.1016/j.fct.2010.12.013

Taha NM, Mandour AA, Lebda MA. Antioxidative and cardio-protective effects of ethanolic extract of ginger on triton wr-1339 induced hyperlipidemia in rats. Int J Chem Res. 2014;6(1):153–8.

Rasyidah TI, Suhana S, Kaswandi MA, Noah RM. Evaluation of Antioxidant Activity of Zingiber Officinale ( Ginger ) on Formalin-Induced Testicular Toxicity in Rats. J Med Bioeng. 2014;3(3):149–53. DOI: https://doi.org/10.12720/jomb.3.3.149-153

Kulkarni RA, Deshpande AR. Anti-inflammatory and antioxidant effect of ginger in tuberculosis. Journal of Complementary and Integrative Medicine. 2016 Jun 1;13(2):201-6. DOI: https://doi.org/10.1515/jcim-2015-0032

Yu S, Zhou X, Hou B, Tang B, Li J, Zhang B. Protective effect of rosuvastatin treatment by regulating oxidized low-density lipoprotein expression in a rat model of liver fibrosis. Biomedical reports. 2016 Sep 1;5(3):311-6. DOI: https://doi.org/10.3892/br.2016.722

Elhemely MA, Omar HA, Ain-shoka AA, El-latif HAA, Abo-youssef AM, El Sherbiny GA. Rosuvastatin and ellagic acid protect against isoproterenol-induced myocardial infarction in hyperlipidemic rats. Beni-Suef Univ J Basic Appl Sci. Elsevier Ltd; 2014;3(4):239–46. DOI: https://doi.org/10.1016/j.bjbas.2014.10.010

Yunoki K, Nakamura K, Miyoshi T, Enko K, Kohno K, Morita H, et al. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction. Atherosclerosis. Elsevier Ireland Ltd; 2011;217(2):486–91. DOI: https://doi.org/10.1016/j.atherosclerosis.2011.04.019

Samanta A, Patra A, Mandal A, Roy S, Mandal S, Das K, Sinha B, Kar S, Nandi DK. Physiological Indications and Gut-Microbial Community in Army Personnel in High-Altitude and Base-Line Environments: A Comparative Study. Jordan Journal of Biological Sciences (JJBS). 2018:2141.

Attia AMM, Ibrahim FAA, Nabil GM, Aziz SW. Antioxidant effects of ginger ( Zingiber officinale Roscoe ) against lead acetate-induced hepatotoxicity in rats. African J Pharm Pharmacol. 2013;7(20):1213–9. DOI: https://doi.org/10.5897/AJPP2013.3465

Shalaby MA, Saifan HY. Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats. J Intercult Ethnopharmacol. 2014;3(4):144–9. DOI: https://doi.org/10.5455/jice.20140818050741

Santiago LA. Effect of fenofibrate on free radicals in vitro, lipid peroxides, antioxidant enzymes and liver transaminases in hyperlipidemic mice. Int J Res Dev Pharm Life Sci. 2013;2(4):511–8.

Sowmya P, Muthiah NS, Susshmitha R, Arvinth A. Study of liver function abnormalities during statin therapy in a tertiary care center. J Chem Pharm Res. 2016;8(7):515–9.

Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Liver transplantation. 2009 May 1;15(5):504-8. DOI: https://doi.org/10.1002/lt.21710

Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA, Knopp RH, Lipka LJ, LeBeaut AP, Yang B, Mellars LE. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clinical therapeutics. 2001 Aug 1;23(8):1209-30. DOI: https://doi.org/10.1016/S0149-2918(01)80102-8



How to Cite

Dizaye K, Mohammed H. HYPOLIPIDEMIC EFFICACY OF ZINGIBER OFFICINALE EXTRACT IN COMPARISON WITH FENOFIBRATE, ROSUVASTATIN AND EZETIMIBE IN HYPERLIPIDEMIC RATS. JSMC [Internet]. 2019 Sep. 21 [cited 2024 May 28];9(3):209-18. Available from: https://jsmc.univsul.edu.iq/index.php/jsmc/article/view/jsmc-10208